Discover the latest drugs and treatment options in the Psoriasis Pipeline. Dive into DelveInsight's comprehensive report ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other most undervalued biotech stocks to invest in. On February 21, Jared Holz, Mizuho Securities ...

In work conducted by Jining Medical University investigators, synthesis and optimization of a previously reported ATP-competitive pyrrolo[2,3-b]pyridine-based glycogen synthase kinase 3β (GSK-3β) ...

State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, International ...

Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.

Mixed Lineage Kinase Domain-Like Protein; TRADD, TNFR-Associated Death Domain; FADD, Fas-Associated Death Domain; Casp8, Caspase-8; cIAP1, Cellular Inhibitor of Apoptosis Protein 1; TRAF, TNF Receptor ...

The first designs have been released of the housing-led redevelopment of GlaxoSmithKline’s former west London HQ, drawn up by a team including Haworth Tompkins, Metropolitan Workshop, dRMM and Studio ...

We look forward to evaluating its potential in patients.” MRANK-106 is a novel, orally available dual inhibitor of WEE1 and YES1 kinases discovered using MindRank’s proprietary AI platforms. MRANK-106 ...